Grewal Udhayvir Singh, Mavuram Sreecharan, Bai Nancy, Ramadas Poornima
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana.
Department of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Louisiana.
Proc (Bayl Univ Med Cent). 2021 Jun 29;34(6):705-707. doi: 10.1080/08998280.2021.1936854. eCollection 2021.
COVID-19 (coronavirus disease-19) is associated with an increased risk for thrombosis due to endothelial dysfunction and hyperactivation of the immune system induced by the virus. Most cases of venous thromboembolism associated with COVID-19 are either pulmonary emboli or deep vein thromboses. Ovarian vein thrombosis is a rare condition most commonly seen in the postpartum period. This report describes a case of COVID-19-associated ovarian vein thrombosis in a nonpregnant woman with no evidence of underlying inherited coagulopathy.
新型冠状病毒肺炎（COVID-19）与血栓形成风险增加有关，这是由病毒引起的内皮功能障碍和免疫系统过度激活所致。与COVID-19相关的静脉血栓栓塞大多数病例为肺栓塞或深静脉血栓形成。卵巢静脉血栓形成是一种罕见病症，最常见于产后时期。本报告描述了一名非妊娠女性发生COVID-19相关卵巢静脉血栓形成的病例，该女性无潜在遗传性凝血病证据。
